Trimethoprim-sulphamethoxazole as primary Pneumocystis carinii prophylaxis does not increase serum homocysteine levels in HIV-positive subjects

European Journal of Internal Medicine

Volumn 12, Issue 4, 2001, Pages 363-365

  Smulders, Yvo M ^a   Spoelstra de Man, Angelique M E ^b   Slaats, Ed H ^b   Weigel, Hugo M ^b   Stehouwer, Coen D A ^a   Jos Frissen, P H ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Acquired immunodeficiency syndrome; HIV infection; Homocysteine; Pneumocystis carinii; Prophylaxis; Trimethoprim; Trimethoprim sulphamethoxazole

Indexed keywords

COTRIMOXAZOLE; HOMOCYSTEINE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERHOMOCYSTEINEMIA; INFECTION PREVENTION; MALE; PNEUMOCYSTIS PNEUMONIA;

EID: 0034963259     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(01)00134-0     Document Type: Article

References (12)

1. Homocysteine and atherothrombosis
2. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
3. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy
4. Trimethoprim and fasting plasma homocysteine
5. Drugs and folate metabolism
6. Glutathione homeostasis is disturbed in CD4-positive lymphocytes of HIV-seropositive individuals
7. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
8. Severe premature coronary artery disease with protease inhibitors
9. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
10. Total homocysteine in plasma or serum: methods and clinical applications
11. Inhibitor binding analysis of dihydrofolate reductase from various species
12. Folic acid supplementation prevents deficient folate levels and hyperhomocysteinemia during long-term, low-dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention